Cargando…
Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows
Myasthenia gravis (MG) is an antibody-mediated neuromuscular disease affecting the neuromuscular junction. In most cases, autoantibodies can be detected in the sera of MG patients, thus aiding in diagnosis and allowing for early screening. However, there is a small proportion of patients who have no...
Autores principales: | Vinciguerra, Claudia, Bevilacqua, Liliana, Lupica, Antonino, Ginanneschi, Federica, Piscosquito, Giuseppe, Rini, Nicasio, Rossi, Alessandro, Barone, Paolo, Brighina, Filippo, Di Stefano, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526522/ https://www.ncbi.nlm.nih.gov/pubmed/37759888 http://dx.doi.org/10.3390/brainsci13091286 |
Ejemplares similares
-
Frequency and Correlates of Mild Cognitive Impairment in Myasthenia Gravis
por: Iacono, Salvatore, et al.
Publicado: (2023) -
Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
por: Lupica, Antonino, et al.
Publicado: (2022) -
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016) -
Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
por: Di Stefano, Vincenzo, et al.
Publicado: (2022) -
Complement deposition at the neuromuscular junction in seronegative myasthenia gravis
por: Hoffmann, Sarah, et al.
Publicado: (2020)